DK0517986T3 - Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater - Google Patents
Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparaterInfo
- Publication number
- DK0517986T3 DK0517986T3 DK91401602.7T DK91401602T DK0517986T3 DK 0517986 T3 DK0517986 T3 DK 0517986T3 DK 91401602 T DK91401602 T DK 91401602T DK 0517986 T3 DK0517986 T3 DK 0517986T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparing
- processes
- same
- pharmaceutical compositions
- erythrocytes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91401602A EP0517986B1 (en) | 1991-06-14 | 1991-06-14 | Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0517986T3 true DK0517986T3 (da) | 1998-03-30 |
Family
ID=8208584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91401602.7T DK0517986T3 (da) | 1991-06-14 | 1991-06-14 | Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater |
Country Status (10)
Country | Link |
---|---|
US (1) | US5753221A (da) |
EP (1) | EP0517986B1 (da) |
JP (1) | JPH06510742A (da) |
AT (1) | ATE157879T1 (da) |
CA (1) | CA2102619A1 (da) |
DE (1) | DE69127615T2 (da) |
DK (1) | DK0517986T3 (da) |
ES (1) | ES2109260T3 (da) |
GR (1) | GR3025488T3 (da) |
WO (1) | WO1992022306A1 (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5409710A (en) * | 1993-04-20 | 1995-04-25 | Endocon, Inc. | Foam cell drug delivery |
HUT76331A (en) * | 1994-07-15 | 1997-08-28 | Lepetit Spa | Dinucleoside-5',5'-pyrophosphates |
DE69732225T2 (de) * | 1997-05-05 | 2005-06-23 | Dideco S.R.L., Mirandola | Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür |
CA2332986C (en) | 1998-05-26 | 2009-09-08 | Lifecell Corporation | Cryopreservation of human red blood cells |
US20100040546A1 (en) * | 2008-08-13 | 2010-02-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Biological targeting compositions and methods of using the same |
US8211656B2 (en) | 2008-08-13 | 2012-07-03 | The Invention Science Fund I, Llc | Biological targeting compositions and methods of using the same |
US20120034156A1 (en) * | 2010-08-03 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Artificial cells |
US20100042072A1 (en) * | 2008-08-13 | 2010-02-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Biological targeting compositions and methods of using the same |
WO2010025322A2 (en) * | 2008-08-28 | 2010-03-04 | The Florida International University Board Of Trustees | Magnetic nanodelivery of therapeutic agents across the blood brain barrier |
EP3071515A2 (en) | 2013-11-18 | 2016-09-28 | Rubius Therapeutics, Inc. | Synthetic membrane-receiver complexes |
BR112016022814A8 (pt) | 2014-04-01 | 2021-07-06 | Rubius Therapeutics Inc | composição farmacêutica e seu método de preparação, ácido nucleico, e dispositivo médico ou kit médico |
KR20200104887A (ko) | 2017-12-23 | 2020-09-04 | 루비우스 테라퓨틱스, 아이엔씨. | 인공 항원 제시 세포 및 사용 방법 |
RU2020132924A (ru) | 2018-03-08 | 2022-04-11 | Рубиус Терапьютикс, Инк. | Терапевтические клеточные системы и способы лечения рака и инфекционных заболеваний |
EP3958877A1 (en) | 2019-04-26 | 2022-03-02 | Rubius Therapeutics, Inc. | Buffered compositions including enucleated erythroid cells |
JP2022533252A (ja) | 2019-05-24 | 2022-07-21 | ルビウス セラピューティクス, インコーポレイテッド | 脱核赤血球細胞を生成する方法 |
US20210130780A1 (en) | 2019-11-04 | 2021-05-06 | Rubius Therapeutics, Inc. | Methods of generating enucleated erythroid cells using myo-inositol |
EP4055148A1 (en) | 2019-11-04 | 2022-09-14 | Rubius Therapeutics, Inc. | Methods of generating enucleated erythroid cells using taurine or hypotaurine |
WO2022150578A1 (en) | 2021-01-08 | 2022-07-14 | Rubius Therapeutics, Inc. | Methods of treating a tumor in a human subject |
TW202241471A (zh) | 2021-01-08 | 2022-11-01 | 美商盧比亞斯治療公司 | 提高個體中NKp30陽性淋巴球的方法及其用途 |
TW202304482A (zh) | 2021-03-14 | 2023-02-01 | 美商盧比亞斯治療公司 | 於個體中增加nkg2d陽性淋巴球之方法及其用途 |
TW202317179A (zh) | 2021-06-03 | 2023-05-01 | 美商盧比亞斯治療公司 | 在個體中治療hpv16-陽性或hpv16-相關的癌症之方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2529463B1 (fr) * | 1982-07-05 | 1986-01-10 | Centre Nat Rech Scient | Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus |
IL86650A0 (en) * | 1987-06-30 | 1988-11-30 | Biophor Corp | Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane |
FR2653561A1 (fr) * | 1989-10-19 | 1991-04-26 | Fondation Nale Transfusion San | Hetero-anticorps anti-rhd et composition pharmaceutique les contenant. |
-
1991
- 1991-06-14 DK DK91401602.7T patent/DK0517986T3/da active
- 1991-06-14 EP EP91401602A patent/EP0517986B1/en not_active Expired - Lifetime
- 1991-06-14 ES ES91401602T patent/ES2109260T3/es not_active Expired - Lifetime
- 1991-06-14 AT AT91401602T patent/ATE157879T1/de not_active IP Right Cessation
- 1991-06-14 DE DE69127615T patent/DE69127615T2/de not_active Expired - Fee Related
-
1992
- 1992-06-09 CA CA002102619A patent/CA2102619A1/en not_active Abandoned
- 1992-06-09 WO PCT/EP1992/001291 patent/WO1992022306A1/en active Application Filing
- 1992-06-09 JP JP4510441A patent/JPH06510742A/ja active Pending
- 1992-06-09 US US08/146,060 patent/US5753221A/en not_active Expired - Fee Related
-
1997
- 1997-11-26 GR GR970403137T patent/GR3025488T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69127615D1 (de) | 1997-10-16 |
GR3025488T3 (en) | 1998-02-27 |
EP0517986A1 (en) | 1992-12-16 |
EP0517986B1 (en) | 1997-09-10 |
ATE157879T1 (de) | 1997-09-15 |
DE69127615T2 (de) | 1998-03-19 |
JPH06510742A (ja) | 1994-12-01 |
ES2109260T3 (es) | 1998-01-16 |
US5753221A (en) | 1998-05-19 |
CA2102619A1 (en) | 1992-12-15 |
WO1992022306A1 (en) | 1992-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0517986T3 (da) | Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater | |
DK552684A (da) | Desulfatohirudiner samt deres fremstilling og anvendelse | |
DK0503548T3 (da) | Cykliske ureaderivater, lægemidler indeholdende disse, og fremgangsmåde til deres fremstilling. | |
ATE114113T1 (de) | Verwendung von droloxifen bei der behandlung von knochenerkrankungen. | |
DK0791571T3 (da) | Benzoylderivater | |
DK1200418T3 (da) | Nematodicide trifluorbutener | |
ES2051641B1 (es) | Procedimientos para la preparacion de compuestos derivados de tiourea. | |
DK0513543T3 (da) | Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf | |
FI913478A0 (fi) | Diazinderivat. | |
BR0012970A (pt) | Compostos e composições antipicornavirais, seus usos farmacêuticos e materiais para a sua sìntese | |
DK0497816T3 (da) | Behandling af HIV-infektioner og forbindelser anvendelige derved | |
DK0516588T3 (da) | Substituerede diaminophthalimider og analoger | |
TR200101649T2 (tr) | Piperazin türevleri. | |
FI945975A (fi) | Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
DK161642C (da) | Phenoxy- eller phenylthioalkanderivater, skadedyrsbekaempende praeparat indeholdende saadanne derivater samt fremgangsmaade til bekaempelse af insekter og acari | |
DK462687A (da) | Forbindelse til behandling af retrovirusinfektioner. | |
EE200100125A (et) | TAN-1057 derivaadid | |
DK0750616T3 (da) | Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser | |
DK418986D0 (da) | Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf | |
DK47688D0 (da) | 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiaziner, deres fremstilling og anvendelse som laegemiddel | |
DK190983A (da) | 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor | |
DE69402004D1 (de) | Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen | |
DK0538690T3 (da) | Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler | |
DK0470989T3 (da) | Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer | |
TH9666EX (th) | นิวคลีโอไซด์ที่ใช้ในการรักษาโรค |